Management of Persistent Hypertriglyceridemia with Elevated GGT

Assessment and Diagnosis

The American College of Cardiology suggests that patients with persistent hypertriglyceridemia (TG 150-250 mg/dL) despite being on Vascepa (icosapent ethyl) and Crestor (rosuvastatin) should be further evaluated 1
Elevated gamma-glutamyl transferase (GGT) suggests potential liver involvement or alcohol consumption, according to the American College of Cardiology 2
Normal liver enzymes and physical examination showing no jaundice or abdominal abnormalities are important considerations in the assessment of patients with hypertriglyceridemia, as noted by the American College of Cardiology 3

The American College of Cardiology recommends that alcohol consumption assessment is critical, as alcohol significantly exacerbates hypertriglyceridemia and can elevate GGT, with even moderate alcohol consumption (1 ounce daily) corresponding to 5-10% higher triglycerides 4
Complete alcohol abstinence should be recommended, as alcohol can precipitate hypertriglyceridemic pancreatitis in at-risk individuals, according to the American College of Cardiology 4
Medication review for drugs that may raise triglycerides is an important step in managing hypertriglyceridemia, as suggested by the American College of Cardiology 5
Assessment of glycemic control (even if not diabetic) and evaluation of dietary patterns, particularly intake of refined carbohydrates, are crucial in addressing secondary causes of hypertriglyceridemia, according to the American College of Cardiology 6, 3

The American College of Cardiology recommends adding fibrate therapy to the current regimen of Vascepa and Crestor for patients with severe hypertriglyceridemia 6
Fibrates are first-line treatment for severe hypertriglyceridemia and can be added when other therapies are inadequate, as noted by the American College of Cardiology 6
Continuing statin therapy (Crestor) provides cardiovascular benefit and modest triglyceride reduction, according to the American College of Cardiology 5
High-intensity statin therapy is associated with greater triglyceride reduction than moderate-intensity statins, as suggested by the American College of Cardiology 7
Maintaining Vascepa (icosapent ethyl) has shown cardiovascular benefit in patients with elevated triglycerides, according to the American College of Cardiology 1

Implementing strict dietary changes, including reducing dietary fat to 10-15% of total calories, eliminating added sugars and refined carbohydrates, and increasing consumption of omega-3 rich foods, is recommended by the American College of Cardiology 6, 3, 4
Increasing physical activity, with at least 150 minutes per week of moderate-intensity aerobic activity, can decrease triglycerides by approximately 11%, as noted by the American College of Cardiology 8
Regular aerobic training and resistance training can decrease triglycerides by about 11% and 6%, respectively, according to the American College of Cardiology 8
Weight management, with a 5-10% body weight reduction, can result in up to 20% reduction in triglycerides, as suggested by the American College of Cardiology 2

Rechecking lipid panel and liver enzymes in 4-12 weeks after implementing changes is recommended by the American College of Cardiology 5
Assessing compliance with lifestyle modifications and medication regimen is crucial in managing hypertriglyceridemia, according to the American College of Cardiology 2

Failing to address alcohol consumption, which is a major contributor to both hypertriglyceridemia and elevated GGT, is a common pitfall, as noted by the American College of Cardiology 4
Focusing only on triglyceride levels without addressing overall cardiovascular risk is another common pitfall, according to the American College of Cardiology 1